Strange Side Effect Found Among Ozempic Users-and It Has to Do With Smell and Taste

Key Points:

• Researchers at Hebrew University of Jerusalem found that people with type 2 diabetes taking GLP-1 medications like semaglutide have a 48% higher likelihood of developing smell or taste disturbances compared to those on other diabetes drugs, though the absolute risk remains small (0.37% vs. 0.22%).
• The study analyzed medical records from over 439,000 patients across 170 healthcare centers worldwide and identified conditions such as anosmia, parosmia, and parageusia linked to GLP-1 use.
• As the study is retrospective and observational, it cannot establish a direct cause-and-effect relationship, and previous research has sometimes suggested GLP-1s might improve sensory perception, indicating the effects may be complex and multifactorial.
• Researchers emphasize the need for further studies to understand the mechanisms, drug-specific effects, symptom severity, and long-term impacts on diet and quality of life, noting that GLP-1 receptors are present in taste buds and the olfactory bulb.
• While not advising patients to stop GLP-1 medications, the authors urge clinicians and patients to monitor for sensory changes, as early detection could allow interventions like olfactory training to help restore smell and taste.